Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
5.44
-0.12 (-2.16%)
At close: Nov 4, 2024, 4:00 PM
5.48
+0.04 (0.74%)
After-hours: Nov 4, 2024, 5:30 PM EST

Skye Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
1653415251119
Upgrade
Market Cap Growth
986.42%126.97%-40.22%130.88%-42.17%-65.37%
Upgrade
Enterprise Value
96331716821
Upgrade
Last Close Price
5.442.724.0513.0010.0032.63
Upgrade
PE Ratio
--0.51-0.46-2.48-1.34-2.70
Upgrade
PB Ratio
2.10-15.76-4.924.2223.7933.83
Upgrade
P/FCF Ratio
-11.38-2.41-1.15-3.77-1.77-3.08
Upgrade
P/OCF Ratio
-11.41-2.41-1.16-3.82-1.77-3.08
Upgrade
EV/EBITDA Ratio
-6.64-2.46-0.93-2.00-1.25-3.09
Upgrade
EV/EBIT Ratio
-6.60-2.43-0.93-1.99-1.25-3.09
Upgrade
EV/FCF Ratio
-7.40-2.36-1.32-2.38-1.30-3.40
Upgrade
Debt / Equity Ratio
0.07-2.16-0.660.363.320.71
Upgrade
Debt / FCF Ratio
-0.26-0.33-0.15-0.33-0.25-0.06
Upgrade
Quick Ratio
5.210.140.122.303.141.88
Upgrade
Current Ratio
6.070.840.742.463.382.05
Upgrade
Return on Equity (ROE)
-130.08%--1364.20%-269.90%-1313.66%-
Upgrade
Return on Assets (ROA)
-30.92%-80.28%-120.69%-78.31%-168.39%-209.69%
Upgrade
Return on Capital (ROIC)
-39.27%-1159.18%-328.19%-98.60%-272.61%-
Upgrade
Earnings Yield
-25.62%-112.07%-131.64%-34.42%-61.18%5.67%
Upgrade
FCF Yield
-11.97%-41.57%-86.75%-26.52%-56.53%-32.51%
Upgrade
Buyback Yield / Dilution
-592.34%-215.43%-36.56%-75.70%-36.48%-39.95%
Upgrade
Total Shareholder Return
-592.34%-215.43%-36.56%-75.70%-36.48%-39.95%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.